News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Dynavax Technologies Corporation Sinks on Discounted Offering, CEO Exit
May 9, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
May 9 (Reuters) - Shares of Dynavax Technologies Corp , which priced its public offering at a steep discount, fell as much as 22 percent a day after the biopharmaceutical company said its chief executive intends to step down.
Twitter
LinkedIn
Facebook
Email
Print
IPO
People
Dynavax Technologies
MORE ON THIS TOPIC
IPO tracker
Avalyn plots IPO to push inhaled pulmonary fibrosis pipeline through clinic
April 9, 2026
·
7 min read
·
Tristan Manalac
Deals
Roche sticks with C4T, adding up to $1B for molecular glue partnership
April 9, 2026
·
2 min read
·
Tristan Manalac
C-suite
Novavax Shareholder Vows To Fight CEO Pay Package, End ‘Dogmatic Leadership’
April 8, 2026
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data
April 8, 2026
·
3 min read
·
Tristan Manalac